Parallax Volatility Advisers’s Medifast MED Stock Holding History

Parallax Volatility Advisers’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-60,000	Closed	-$7.7M	–	3011
2019 Q2	$7.7M	Buy	+60,000	New	+$8.34M	0.01%	590
2017 Q1	–	Sell	-1,500	Closed	-$62K	–	4223
2016 Q4	$62K	Buy	+1,500	New	+$60.4K	﹤0.01%	2394
2015 Q2	–	Sell	-500	Closed	-$15K	–	4420
2015 Q1	$15K	Sell	500 -7,900	-94%	-$251K	﹤0.01%	3749
2014 Q4	$283K	Buy	8,400 +1,600	+24%	+$49.8K	﹤0.01%	2535
2014 Q3	$223K	Buy	6,800 +2,300	+51%	+$70.6K	﹤0.01%	2389
2014 Q2	$137K	Sell	4,500 -8,800	-66%	-$274K	﹤0.01%	2273
2014 Q1	$389K	Buy	+13,300	New	+$356K	﹤0.01%	1126
2013 Q3	–	Sell	-1,000	Closed	-$26K	–	3150
2013 Q2	$26K	Buy	+1,000	New	+$26.3K	﹤0.01%	1881

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Parallax Volatility Advisers's MED Position: Q2 2021 in Review

Parallax Volatility Advisers sold out of Medifast (MED) in Q2 2021, closing a stake of 1,085 shares — an estimated $230K sold.

Parallax Volatility Advisers first reported a position in MED in Q3 2013 and held it in 9 quarters. The position peaked at $230K in Q1 2021. 301 funds tracked by Wall St. Rank hold MED as of Q2 2021.

Parallax Volatility Advisers reported no remaining Medifast position as of Q2 2021 after selling out during the quarter.
Parallax Volatility Advisers sold 1,085 Medifast shares in Q2 2021, an estimated $230K.
Parallax Volatility Advisers first reported a position in Medifast in Q3 2013 and held it in 9 quarters.
Parallax Volatility Advisers's Medifast position peaked at $230K in Q1 2021.
301 funds tracked by Wall St. Rank held Medifast as of Q2 2021.

Based on Parallax Volatility Advisers's 13F filing for Q2 2021, filed 16 Aug 2021.